Combining single-cell sequencing data to construct a prognostic signature to predict survival, immune microenvironment, and immunotherapy response in gastric cancer patients.

Hu, Bo; Meng, Yan; Qu, Chao; Wang, Bing-Yan; Xiu, Dian-Rong

Hu, Bo; Meng, Yan; Qu, Chao; Wang, Bing-Yan; Xiu, Dian-Rong.

Afiliação

Hu B; Department of General Surgery, Peking University Third Hospital, Beijing, China.
Meng Y; Department of General Surgery, Peking University Third Hospital, Beijing, China.
Qu C; Department of General Surgery, Peking University Third Hospital, Beijing, China.
Wang BY; Department of General Surgery, Peking University Third Hospital, Beijing, China.
Xiu DR; Department of General Surgery, Peking University Third Hospital, Beijing, China.

Front Immunol ; 13: 1018413, 2022.

Article em En | MEDLINE | ID: mdl-36300104

Assuntos

Neoplasias Gástricas; Humanos; Neoplasias Gástricas/genética; Neoplasias Gástricas/terapia; Neoplasias Gástricas/metabolismo; Prognóstico; Instabilidade de Microssatélites; Imunoterapia; RNA; Microambiente Tumoral/genética

Palavras-chave

gastric cancer; immune microenvironment; immunotherapy; prognosis; single-cell sequencing

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google